06:41 GMT +310 December 2019
Listen Live
    Russian Healthcare Minister Veronika Skvortsova demostrates Anti-Ebola fever vaccine packages at Gamalei Research Institute of Epidemiology and Microbiology

    Russian Ebola Vaccine Passes First Phase of Clinical Tests on 60 Volunteers

    © Sputnik / Ramil Sitdikov
    World
    Get short URL
    283
    Subscribe

    The Russian vaccination against Ebola has passed the first phase of clinical tests on 60 volunteers and has proven its effectiveness, the head of Russia’s consumer watchdog said Wednesday.

    MOSCOW (Sputnik) – The vaccination against Ebola created by Russia’s Vektor scientific center has passed the first phase of clinical tests on 60 volunteers and has shown its effectiveness, the head of Russia’s consumer watchdog said Wednesday.

    “We literally turned over all the documents the day before yesterday to the Russian Health Ministry to register the first stage of clinical research…They passed successfully. The vaccine proved to be highly effective with a 100-percent [effectiveness] after two inoculations,” Rospotrebnadzor head Anna Popova said.

    In March, Russia claimed it obtained the legal basis to test a recently-developed Ebola virus vaccine. According to reports, 2,000 Guinea citizens are to be vaccinated during the test.

    Related:

    Africa Appreciates Russia's Help in Fight Against Ebola
    US Redirects $589Mln in Mainly Ebola Funds to Fight Zika Virus
    Liberia Registers Second Ebola Case Months After Epidemic Declared Over
    Is Ebola Back? Disease Kills Woman in Liberia
    Tags:
    effectiveness, test, vaccine, Ebola virus disease (EVD), Rospotrebnadzor, Russia
    Community standardsDiscussion
    Comment via FacebookComment via Sputnik